An Update on BIA-ALCL: What Patients Should Know About Allergan’s Recall of Textured Breast Implants

The July 24, 2019 announcement that Allergan voluntarily recalled their BIOCELL textured breast implants at the request of the FDA has spread quickly, leaving many women feeling confused and concerned about how this decision may personally impact their lives. Here at the American Board of Cosmetic Surgery, our primary objective … Continue reading An Update on BIA-ALCL: What Patients Should Know About Allergan’s Recall of Textured Breast Implants